What is the appropriate work‑up to rule out multiple sclerosis in a patient with a stable T8 syringomyelia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

MRI Work-up to Rule Out MS in a Patient with Stable T8 Syringomyelia

In a patient with stable T8 syringomyelia, perform comprehensive brain and spinal cord MRI with susceptibility-sensitive sequences to rule out MS, as syringomyelia occurs in approximately 4.5% of MS patients and should not preclude the diagnosis when typical demyelinating lesions are present 1, 2.

Recommended Imaging Protocol

Brain MRI (Essential First Step)

Obtain a complete brain MRI with the following sequences 1, 3:

  • 3D T2-FLAIR (most sensitive for periventricular and juxtacortical lesions)
  • 3D T2-weighted sequences
  • 3D T1-weighted sequences
  • Susceptibility-sensitive sequences (SWI or T2*) to assess for central vein sign and paramagnetic rim lesions
  • Post-gadolinium T1-weighted imaging (single dose) to detect active inflammation

Spinal Cord MRI (Critical in This Case)

Given the pre-existing syringomyelia, complete spinal cord imaging is mandatory 1, 3:

  • Sagittal T1-weighted and proton density sequences
  • Sagittal STIR or phase-sensitive inversion recovery
  • Axial T2- or T2-weighted imaging* through any suspicious lesions
  • Post-gadolinium T1-weighted imaging if new lesions are suspected

Optic Nerve MRI

Include fat-saturated sequences of the optic nerves, as this is now recognized as a fifth anatomical location in the 2024 McDonald criteria 1.

Applying the 2024 McDonald Criteria for Dissemination in Space (DIS)

Look for typical MS lesions in at least 4 of 5 anatomical locations 1:

  1. Periventricular (≥1 lesion)
  2. Juxtacortical or cortical (≥1 lesion)
  3. Infratentorial (≥1 lesion)
  4. Spinal cord (≥1 lesion)
  5. Optic nerve (≥1 lesion)

Critical distinction: The syrinx itself does not count as an MS lesion. You must identify discrete T2-hyperintense demyelinating lesions separate from the syringomyelia 2, 4.

Key Imaging Features to Differentiate MS from Syringomyelia

MS Lesions Characteristics:

  • Ovoid periventricular lesions perpendicular to ventricles (Dawson's fingers)
  • Peripheral cord location (typically dorsolateral columns)
  • Short segment (<2 vertebral segments in length)
  • Partial cord involvement on axial images
  • Central vein sign on susceptibility-sensitive sequences (highly specific for MS) 1
  • Paramagnetic rim lesions (indicate chronic active inflammation) 1

Syringomyelia Features:

  • Central cord location (fluid-filled cavity)
  • Long segment (in this case C5-T12)
  • No enhancement with gadolinium (unless complicated)
  • CSF signal intensity on all sequences

Dissemination in Time (DIT)

If initial MRI shows DIS criteria are met, establish DIT by 1:

  • New T2 lesion on follow-up MRI (any timeframe), OR
  • Simultaneous presence of gadolinium-enhancing and non-enhancing lesions on a single scan

Additional Diagnostic Testing

Cerebrospinal Fluid Analysis

Perform lumbar puncture to assess 2, 5:

  • Oligoclonal bands (present in ~95% of MS patients)
  • IgG index elevation
  • Cell count and protein (to exclude alternative diagnoses)

Red flag: Absence of oligoclonal bands with marked pleocytosis and very high protein should prompt consideration of alternative diagnoses like MOGAD 5.

Serology

Test for MOG-IgG and AQP4-IgG antibodies to exclude MOGAD and NMOSD, especially if 6, 5:

  • Longitudinally extensive transverse myelitis (LETM ≥3 segments) is present
  • Brain MRI is normal or shows only nonspecific lesions
  • Atypical clinical features develop

Critical Pitfalls to Avoid

  1. Do not assume new symptoms are syrinx-related without comprehensive imaging 4. MS can develop in patients with pre-existing spinal pathology.

  2. Do not overlook brain imaging even when spinal symptoms predominate. Up to 12% of MS patients may have minimal or no brain lesions initially, but brain MRI remains essential 7.

  3. Do not diagnose MS based on spinal lesions alone when brain MRI is normal or shows <4 lesions, unless you can demonstrate DIS across multiple anatomical regions including the cord 7.

  4. Recognize that syringomyelia and MS can coexist 2. The presence of syringomyelia does not exclude MS when typical demyelinating lesions are identified in characteristic locations.

  5. Use susceptibility-sensitive sequences to increase diagnostic specificity. The central vein sign and paramagnetic rim lesions are pathologically specific for MS and can be decisive in ambiguous cases 1.

When Imaging is Insufficient

If conventional MRI findings are equivocal after complete brain and spinal cord imaging 1:

  • Obtain susceptibility-sensitive sequences if not already performed
  • Consider follow-up MRI at 3-6 months to demonstrate new lesion development
  • Ensure CSF analysis has been completed
  • Evaluate for visual evoked potentials and optical coherence tomography to detect subclinical optic nerve involvement

The diagnosis should never rest on imaging alone—at least one clinical event consistent with demyelination remains essential, though the 2024 criteria now allow diagnosis in radiologically isolated syndrome with appropriate findings 1, 6.

References

2
Research

Not The Classic Waxing and Waning Multiple Sclerosis: A Case Report.

Journal of Brown hospital medicine, 2025

Related Questions

Can multiple sclerosis (MS) occur without demyelinating lesions?
What is the recommended evaluation and treatment for a patient experiencing drifting when walking, cramping in multiple muscles, and sulcal prominence on an MRI (Magnetic Resonance Imaging) brain scan?
How should I manage a patient with dysautonomia and spinal cord syndrome who has negative MRI, EMG, anti‑myelin oligodendrocyte glycoprotein (MOG) antibodies, neuromyelitis optica (NMO) antibodies, and oligoclonal bands?
Given my cervical spine MRI showing minimal increased T2 signal at C3‑C5 and bilateral cerebellar white‑matter T2 hyperintensity, a normal neurologist exam, and a positive RON antibody level of 4.7, what further diagnostic evaluations and management should I pursue?
In a patient with a positive antinuclear antibody, markedly elevated anti‑RNP antibodies, nonspecific T2 hyperintensity in the lumbar spinal cord and cerebellar white matter, and progressive proximal muscle weakness after infection, what is the most likely diagnosis and expected prognosis?
Can dapagliflozin and empagliflozin be prescribed for patients with heart failure with reduced ejection fraction who do not have diabetes mellitus?
What is the recommended treatment for uncomplicated superficial skin fungal infections such as tinea corporis, tinea cruris, and tinea pedis?
What is the appropriate prophylactic dose of macrobid (nitrofurantoin macrocrystals) for an adult patient with recurrent uncomplicated urinary tract infections who has normal renal function (eGFR ≥ 30 mL/min), no G6PD deficiency, and is not pregnant?
When should oral fluconazole be used for dermatophyte infections (tinea corporis, cruris, pedis) and what is the recommended dosing regimen?
What is the common presentation of disseminated tuberculosis in an immunocompetent patient who has been immunized with Bacillus Calmette-Guérin (BCG) vaccine?
Can an avulsion fracture at the volar (palmar) base of the middle phalanx involve the flexor digitorum profundus tendon?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.